It is well-established the activation of AhR in immune cells hinders efficient antitumor immunity via stimulation of antigen-presenting DCs, tumor-associated macrophages (TAMs), immunosuppressive Tregs and modulation of effector CD8 and CD4 T-cell functions (111). Here, CD4 is linked to neoplasm.